Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
mattiafalchetto.osti@uniroma1.it
Mattia Falchetto Osti
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
mattiafalchetto.osti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Leptomeningeal Carcinomatosis in Early Gastric Cancer: A Case Report and Literature Review
HEALTHCARE
2024
Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers
JOURNAL OF PERSONALIZED MEDICINE
2023
Efficacy of Residual Site Radiation Therapy (ISRT) in Patients with Primary Mediastinal Lymphoma with Deauville Score 4 Following R-CHT: Results of a Retrospective Mono Institutional Study
JOURNAL OF CLINICAL MEDICINE
2023
Lymph Node Metastasis in Extraperitoneal Rectal Cancer After Neoadjuvant Therapy: An Unsolved Problem?
ANTICANCER RESEARCH
2023
Stereotactic body radiation therapy for the treatment of lymph node metastases: a retrospective mono-institutional study in a large cohort of patients
FRONTIERS IN ONCOLOGY
2023
Low Anterior Resection Syndrome (LARS) after Surgery for Rectal Cancer: An Inevitable Price to Pay for Survival, or a Preventable Complication?
JOURNAL OF CLINICAL MEDICINE
2023
Rectal cancer response to neoadjuvant chemoradiotherapy evaluated with MRI: development and validation of a classification algorithm
EUROPEAN JOURNAL OF RADIOLOGY
2022
AIRO breast caner group "Best Clinical Practice" 2022 update
TUMORI
2022
Quality of life and sexual functioning among endometrial cancer patients treated with one week adjuvant high-dose-rate vaginal brachytherapy schedule
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2022
External validation of a composite bio-humoral index in anal cancer patients undergoing concurrent chemoradiation
RADIOTHERAPY AND ONCOLOGY
2022
The Role of Indocyanine Green in Laparoscopic Low Anterior Resections for Rectal Cancer Previously Treated With Chemo-radiotherapy: A Single-center Retrospective Analysis
ANTICANCER RESEARCH
2022
Adjuvant vaginal interventional radiotherapy in early-stage non-endometrioid carcinoma of corpus uteri: a systematic review
JOURNAL OF CONTEMPORARY BRACHYTHERAPY
2021
Radiotherapy with intensity-modulated (IMRT) techniques in the treatment of anal carcinoma (RAINSTORM): a multicenter study on behalf of AIRO (Italian association of radiotherapy and clinical oncology) gastrointestinal study group
CANCERS
2021
Resilience in radiotherapy services during the COVID-19 emergency: collaboration between the regional radiation oncology departments of Lazio, Abruzzo and Molise
ANTICANCER RESEARCH
2021
A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations
CLINICAL & TRANSLATIONAL ONCOLOGY
2021
Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study
CLINICAL BREAST CANCER
2021
Stereotactic and hypofractionated radiotherapy associated with immune checkpoint inhibitor drugs: Analysis of local control, toxicity, and outcome in a single research centre case study
ANTICANCER RESEARCH
2021
Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
FRONTIERS IN ONCOLOGY
2021
Stereotactic body radiation therapy (SBRT) for patients with oligometastatic/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study
CANCER TREATMENT AND RESEARCH COMMUNICATIONS
2021
Stereotactic Body Radiation Therapy Boost in Patients With Cervical Cancer Ineligible for Brachytherapy
CANCER DIAGNOSIS & PROGNOSIS
2021
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
La radioterapia stereotassica frazionata extracranica e le terapie biologiche nel trattamento delle neoplasie solide metastatiche: analisi del controllo locale e della tossicità nei trattamenti combinati.
VALUTAZIONE DI FATTORI PROGNOSTICI CLINICO-PATOLOGICI IN PAZIENTI CON ADENOCARCINOMA DELLA PROSTATA A RISCHIO INTERMEDIO ED ALTO TRATTATI CON RADIOTERAPIA CURATIVA IPOFRAZIONATA ASSOCIATA AD ORMONOTERAPIA
Radioterapia stereotassica frazionata concomitante a immunoterapia o target-therapy nel trattamento delle metastasi cerebrali.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma